These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 27864143)
21. Orois A; Gara SK; Mora M; Halperin I; Martínez S; Alfayate R; Kebebew E; Oriola J Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703244 [TBL] [Abstract][Full Text] [Related]
22. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]
23. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci. Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407 [TBL] [Abstract][Full Text] [Related]
24. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Xing M Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812 [TBL] [Abstract][Full Text] [Related]
27. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population. de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015 [TBL] [Abstract][Full Text] [Related]
28. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function. Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672 [TBL] [Abstract][Full Text] [Related]
38. Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Pan W; Zhou L; Ge M; Zhang B; Yang X; Xiong X; Fu G; Zhang J; Nie X; Li H; Tang X; Wei J; Shao M; Zheng J; Yuan Q; Tan W; Wu C; Yang M; Lin D Hum Mol Genet; 2016 May; 25(9):1875-84. PubMed ID: 26941397 [TBL] [Abstract][Full Text] [Related]
39. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400 [TBL] [Abstract][Full Text] [Related]
40. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]